Article
How genetic testing can lead to targeted management of XIAP deficiency-related inflammatory bowel disease.
Genetics in medicine : official journal of the American College of Medical Genetics - 1 Feb 2017
Nielsen Ole Haagen, LaCasse Eric Charles
Abstract excerpt
X-linked lymphoproliferative disease type 2 (XLP-2, OMIM 300635) is a primary immunodeficiency caused by the loss of X chromosome-linked inhibitor of apoptosis (XIAP), the X-linked inhibitor of apoptosis gene at Xq25. XLP-2 individuals are susceptible to several specific and potentially fatal infections, such as Epstein-Barr virus (EBV). Children with XIAP-related XLP-2 may present with either familial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
